Showing results (71-80 of 210) with videos related to
Sort By:
Pageof 21
Healthcare (Basel, Switzerland)|June 24, 2022
Relative Efficiency of Radiation Treatment Centers: An Application of Data Envelopment AnalysisTiffany Bayley, Mehmet A Begen, Felipe F Rodrigues, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Development of an efficient semisynthetic modification of FR901459 via a novel regioselective N, O-acyl migrationTakuya Makino, Seiji Yoshimura, Toshio Yamanaka, et al.Journal of Personalized Medicine|March 26, 2025
Enhancing Rural Healthcare Accessibility: A Model for Pharmacogenomics Adoption via an Outreach-Focused Integration StrategyJared Silver, Evan Forman, David Barrett, et al.Immunology|March 24, 2011
Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteasesJohn Puskas, Denise Skrombolas, Abigail Sedlacek, et al.Pain|April 24, 2007
Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer painMark J Edlund, Diane Steffick, Teresa Hudson, et al.Journal of Immunological Methods|February 17, 2010
Dimethyl sulfoxide (DMSO) exposure to human peripheral blood mononuclear cells (PBMCs) abolish T cell responses only in high concentrations and following coincubation for more than two hoursHenrik Kloverpris, Anders Fomsgaard, Amanda Handley, et al.Gynecologic Oncology|July 5, 2013
Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift?Mohamad N Shafiee, Caroline Chapman, David Barrett, et al.Cancer Journal (Sudbury, Mass.)|March 27, 2014
Managing cytokine release syndrome associated with novel T cell-engaging therapiesShannon L Maude, David Barrett, David T Teachey, et al.Annals of Medicine|April 19, 2023
Debridement, antibiotics and implant retention (DAIR) is successful in the management of acutely infected unicompartmental knee arthroplasty: a case seriesAngela Brivio, Talal Al-Jabri, Jurgen Martin, et al.Paediatric Drugs|August 1, 2012
Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignanciesDavid Barrett, Valerie I Brown, Stephan A Grupp, et al.Pageof 21